|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| A61P 43/00 |
| (11) | Number of the document | 3245231 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16702306.8 |
| Date of filing the European patent application | 2016-01-18 | |
| (97) | Date of publication of the European application | 2017-11-22 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/013808 |
| Date | 2016-01-18 |
| (87) | Number | WO 2016/115559 |
| Date | 2016-07-21 |
| (30) | Number | Date | Country code |
| 201562104664 P | 2015-01-16 | US |
| (72) |
CHEN, Yan, US
SHAMAH, Steven M., US
PAZMANY, Csaba, US
DUTTA-SIMMONS, Jui, US
|
| (73) |
Juno Therapeutics, Inc.,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
| (54) | ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR ROR1 |
| ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR ROR1 |